PREFORMED LINE PRODUCTS CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PREFORMED LINE PRODUCTS CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	337	378	421	445	466	517	637	670	594	669
Cost of revenue	227	260	289	304	312	351	422	435	404	461
Gross profit	109	119	132	141	154	166	215	235	190	209
Research and development	2.7	2.1	2.4	3	2.8	3.3	4.5	5.2
Selling and marketing	31.8	34	36.4	36.6	35.6	40.5	45.7	51.1	48.7	52
General and administrative	42.1	43.2	45.4	51.8	56.3	55.3	70.3	74.6	67.5	75.2
Operating income	21.5	26.1	32.9	32.6	40.2	47.5	69.4	84.2	50.8	55.1
Interest expense	0.84	1.06	1.29	2.22	2.4	2.02	3.21	3.91	2.22	1.3
Interest income	0.29	0.43	0.49	0.78	0.26	0.17	0.63	1.81	2.57	2.32
Other non-operating income	-0.53	-0.3	-0.35	-1.17	0.36	1.35	4.34	-1.81	0.01	-9.52
Pre-tax income	21	25.8	32.6	31.5	40.6	48.9	73.7	82.3	50.8	45.6
Income tax	5.7	13.2	6.01	8.12	10.8	13.2	19.3	19	13.7	10.3
Net income to minority interests		0	0	0.03	-0.04	-0.01	0	0.01	0.02	0.02
Net income	15.3	12.7	26.6	23.3	29.8	35.7	54.4	63.3	37.1	35.3
EBITDA	33.5	38.9	45.4	46.4	54	63.1	85.8	103	71.6	78.2
EPS, basic	2.95	2.48	5.28	4.63	6.05	7.28	11.03	12.87	7.56	7.17
EPS, diluted	2.95	2.47	5.21	4.58	5.98	7.19	10.88	12.68	7.50	7.14
Shares, basic (weighted)	5.17	5.1	5.03	5.03	4.92	4.91	4.93	4.92	4.91	4.92
Shares, diluted (weighted)	5.18	5.13	5.11	5.09	4.98	4.97	5	5	4.95	4.94
Dividend per share	0.80	0.80	0.80				0.80	0.80	0.80	0.81

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	30.7	44.4	43.6	38.9	45.2	36.4	37.2	53.6	57.2	83.4
Receivables	63.4	74	73.1	83.5	92.7	98.2	125	107	111	113
Inventory	74.5	77.9	85.3	95.7	97.5	115	147	149	130	149
Other current assets	8.44	2.21	2.88	4.29	3.26	3.22	4.93	7.26	5.51	5.21
Total current assets	189	207	214	232	256	272	328	325	316	363
Property, plant and equipment	105	109	103	124	126	150	175	208	195	223
Lease right-of-use assets			0	12.5	13.1	12.4	10.8	11.7	10.1	9.71
Goodwill	15.8	16.5	15.6	27.8	29.5	28.2	28	29.5	26.7	30.7
Intangible assets	10.5	10	8.46	15.1	14.4
Other non-current assets	10.3	9.72	10.6	14.6	10.9	10.7	7.14	9.19	9.99	9.37
Total assets	341	360	359	434	461	489	568	603	574	654
Accounts payable	22	25.1	26.4	28.3	31.6	42.4	46.8	37.8	42	49.5
Accrued liabilities	10	11.5	11.2	11.8	14.7	13.8	15	28	25.9	29.2
Short-term debt	1.45	1.45	1.45	3.35	5.22	3.12	3.02	6.49	2.43	5.39
Total current liabilities	55.5	62.8	69.5	81.1	104	106	115	111	108	115
Long-term debt	42.9	34.6	25	53.7	33.3	40	68.4	48.8	18.4	32.9
Lease liabilities			0	8.25	8.74	8.15	7.02	7.89	6.54	5.96
Other non-current liabilities	6.5	11.1	8.01	13.6	14.4	12.7	14.9	15.5	14.5	18.8
Total liabilities	117	121	109	165	169	173	210	187	152	178
Total debt	44.4	36	26.4	57.1	38.5	43.2	71.4	55.3	20.8	38.3
Paid-in capital	24.6	29.7	34.4	38.9	43.1	47.8	53.6	61	65.1	67.2
Retained earnings	303	312	334	353	379	411	461	520	553	584
Treasury stock	-59.6	-68.1	-72.3	-79.1	-88.6	-93.8	-99.3	-118	-127	-137
Other comprehensive income	-57.4	-47.4	-59.6	-57.4	-54.6	-61.7	-70	-60.3	-82.9	-53.4
Shareholders' equity	224	239	249	269	292	316	359	416	422	476
Minority interests			0	0.03	-0.01	-0.02	-0.01	-0.01	0.01	0.03
Total equity	224	239	249	269	292	316	359	416	422	476
Total liabilities and equity	341	360	359	434	461	489	568	603	574	654
Shares outstanding	5.12	5.04	5.02	4.99	4.9	4.91	4.92	4.91	4.91	4.91

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	15.3	12.7	26.6	23.3	29.8	35.7	54.4	63.3	37.1	35.3
Depreciation and amortization	12	12.8	12.4	13.7	13.8	15.6	16.4	18.9	20.8	23
Stock-based compensation	1.37	3.06	4.24	4.4	4.09	4.16	4.6	4.95	3.41	4.96
Deferred income tax	2.25	2.44	0.31	-1.27	-3.38	6.54	-2.66	-2.23	1.08	-1.18
Change in receivables	-2.29	-9.21	-4.5	-9.78	-10.5	-11.6	-28	17	-8.71	6.99
Change in inventory	-6.35	-2.21	-13.7	-9.46	0.08	-24.2	-37	-4.95	6.78	-11.9
Change in payables	4.27	4.96	3.05	6.09	6.95	11.6	6.71	2.3	8.6	0.01
Cash from operations	26	33.8	23	27.2	41.6	33.6	26.2	108	67.5	73.5
Capital expenditures	-24.7	-11.2	-9.53	-29.5	-24.6	-18.4	-40.6	-35.3	-14.7	-40.1
Acquisitions	0	0	0	-18.9	0	0	-16.2	-12.1	0	-4.75
Purchases of investments	0	0	-4.69	-0.5	0	0	0	0	-3.15	-0.45
Sales and maturities of investments	0	0	2.95	2.31	0	0	0	0	1.99	1.68
Cash from investing	-28.5	-2.56	-14	-48.8	-14	-18.2	-46.8	-44.8	-12.4	-43.4
Debt issued	70.3	55.6	76	93	90.8	98.9	185	169	96.4	22.2
Debt repaid	-57.7	-64	-85.5	-64.1	-110	-114	-156	-186	-130	-6.63
Stock issued	0.25	1.96	0.22	0.21	0.25	0.41	0.81	2.16	0.21	1.93
Share buybacks	-3.11	-0	-0.19	-2.8	-5.84	-0.18	-0.16	-0.73	-0.23	-1.05
Dividends paid	-4.17	-4.1	-4.09	-4.23	-4.18	-4.13	-4.1	-4.11	-4.08	-4.12
Cash from financing	4.39	-19.6	-9.05	17.7	-23.2	-23.2	22.5	-48.9	-47.8	-9.23
Exchange rate effect	-1.54	1.36	-1.59	-0.78	1.48	-0.89	-1.11	2.44
Net change in cash	0.35	13.1	-1.69	-4.65	5.91	-8.77	0.83	16.4	3.64	26.1
Free cash flow	1.25	22.6	13.4	-2.25	17.1	15.2	-14.4	72.3	52.8	33.3
Interest paid	0.7	1	1.8	2	1.9	1.6	3.1	3.8
Income taxes paid	6.9	3.4	5.6	7.8	7.7	16.9	14.6	21.9	13.1	11.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $423.33 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.4%	Gross profit / revenue.
Operating margin	9.0%	Operating income / revenue.
EBITDA margin	12.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.8%	Pre-tax income / revenue.
Net margin	5.8%	Net income / revenue.
FCF margin	4.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.7%	Cash from operations / revenue.
Effective tax rate	24.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.2%	Net income / average total assets.
Return on invested capital (ROIC)	10.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	12.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	9.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	8.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-7.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	9.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-3.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-4.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-13.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-4.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-13.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	3.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	8.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	41.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	12.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-36.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	14.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	1.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	12.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	10.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	13.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.99x	Current assets / current liabilities.
Quick ratio	1.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.58x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.08x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	5.9%	Total debt / total assets.
Liabilities / assets	29.1%	Total liabilities / total assets.
Net debt	-$35.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.39x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	61.6x	Operating income / interest expense.
Working capital	$264.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$458.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.06x	Revenue / average total assets.
Fixed asset turnover	3.25x	Revenue / average property, plant and equipment.
Inventory turnover	3.43x	Cost of revenue / average inventory.
Days inventory	106 days	365 x average inventory / cost of revenue.
Receivables turnover	4.90x	Revenue / average receivables.
Days sales outstanding	75 days	365 x average receivables / revenue.
Days payables	40 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	141 days	Days inventory + days sales outstanding - days payables.
FCF conversion	79.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	52.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.99	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$154.39	Revenue / diluted weighted shares.
FCF per share	$7.18	Free cash flow / diluted weighted shares.
Operating cash flow per share	$15.05	Cash from operations / diluted weighted shares.
Book value per share	$101.33	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$93.86	Tangible book value / shares outstanding.
Cash per share	$15.62	(Cash + short-term investments) / shares outstanding.
Payout ratio	9.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	11.9%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	5.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.07B	Share price x shares outstanding.
Enterprise value	$2.03B	Market cap + total debt - cash - short-term investments.
P/E	48.0x	Market cap / net income. Only when net income is positive.
P/S	2.80x	Market cap / revenue.
P/B	4.18x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.52x	Market cap / tangible book value, when positive.
P/FCF	60.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	28.7x	Market cap / cash from operations, when positive.
EV/Sales	2.75x	Enterprise value / revenue.
EV/EBIT	30.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	22.4x	Enterprise value / EBITDA, when both are positive.
EV/FCF	59.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.7%	Free cash flow / market cap.
Earnings yield	2.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.2%	Dividends paid over the period / market cap.
Shareholder yield	0.3%	(Dividends paid + share buybacks) / market cap.

What was PREFORMED LINE PRODUCTS CO's revenue in fiscal 2025?

PREFORMED LINE PRODUCTS CO reported revenue of $669.3M for fiscal 2025, 12.7% higher than the year before.

Was PREFORMED LINE PRODUCTS CO profitable in fiscal 2025?

Yes. Net income was $35.3M, a net margin of 5.3%.

How much free cash flow did PREFORMED LINE PRODUCTS CO generate in fiscal 2025?

Cash from operations of $73.5M minus capital expenditures of $40.1M left free cash flow of $33.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PREFORMED LINE PRODUCTS CO